查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
子宮內膜異位症治療市場規模、份額和趨勢分析報告：按治療類型、藥物類別 (NSAID)、給藥途徑、分銷渠道、地區和細分市場預測，2023-2030 年
市場調查報告書
商品編碼
1171058

子宮內膜異位症治療市場規模、份額和趨勢分析報告：按治療類型、藥物類別 (NSAID)、給藥途徑、分銷渠道、地區和細分市場預測，2023-2030 年

Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Drug Class (NSAIDs), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

子宮內膜異位症治療市場的增長和趨勢

根據 Grandview Research 的一份新報告，到 2030 年，全球子宮內膜異位症治療市場預計將達到 32 億美元。從 2023 年到 2030 年，該市場預計將以 13.5% 的複合年增長率增長。市場增長歸因於強大的後期產品管道的存在、全球病例的激增，以及政府和大公司在國家和國際層面採取的幾項提高疾病意識的舉措。

太空中新治療方案的不斷研究和開發預計將為未來幾年的市場增長提供有利可圖的機會。Myovant/Pfizer的 Relugolix 組合片劑、ObsEva 的 Yselty (linzagolix) 和 Ferring Pharmaceuticals/Novartis 的 Quinagolide 預計將作為該領域的主要藥物推動市場增長。

對子宮內膜異位症治療的需求不斷增長，原因是疾病負擔增加和診斷延遲導致病情惡化。2021 年 3 月，世界衛生組織宣布全球約有 10% 的女性生殖人群受到該病的影響。根據論文“子宮內膜異位症診斷延遲對醫療保健資源利用和成本的影響”，與症狀出現後較早診斷的患者相比，首次症狀出現後延遲診斷超過 3 年會增加症狀負擔，導致 50% 的增加醫療費用。

世衛組織、各國政府和私人組織正在戰略性地努力提高人們對子宮內膜異位症及其治療的認識，這有助於市場的增長。例如，2022 年 3 月，美國子宮內膜異位症基金會舉辦了四個週末的虛擬患者和醫生主演計劃，以幫助連接子宮內膜異位症勇士並分享他們與疾病的經驗。此外，2022年3月，英國子宮內膜異位症協會還在子宮內膜異位症行動月期間推出了八點行動計劃。

此外，主要參與者正在通過併購、合作夥伴關係、金融投資和地域擴張等戰略努力來推動子宮內膜異位症治療市場。例如，2021 年 11 月，Organon and Co. 宣布將收購 Forendo Pharma，以幫助開發治療子宮內膜異位症的新藥，包括 Forendo 的 2 期臨床候選藥物 OR-6219。

子宮內膜異位症藥物市場報告要點

從治療類型來看，由於醫生處方率高，激素治療領域將在 2022 年佔據最大份額。

由於 GnRH 激動劑和 GnRH 拮抗劑的高效和市場可用性增加，促性腺激素釋放激素 (GnRH) 細分市場在 2022 年佔據主導地位

到 2022 年，口服製劑將以 48.46% 的給藥途徑份額主導市場。口服製劑是該領域大多數產品最常見和最方便的給藥途徑。

到 2022 年，零售藥店將通過分銷渠道主導市場。此外，預計醫院藥房將出現適度增長。

由於疾病發病率的增加以及人們和醫療保健專業人員對疾病治療的高度認識，2021 年的全球市場由北美主導。

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
    • 段範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 第一次調查的內容
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法：產品流方法
  • 調查假設
  • 二級信息列表
  • 縮略語表
  • 目的

第二章執行摘要

  • 市場快照
  • 段快照
  • 爭用快照

3 子宮內膜異位症治療：市場變量、趨勢和範圍

  • 市場系列展望
  • 繪製滲透率和增長前景
  • 監管狀況
  • 市場動態
  • 市場驅動力分析
    • 疾病負擔加重
    • 疾病意識的增強
    • 增加研發資金
  • 市場約束因素分析
    • 非處方藥和仿製藥的可用性
  • PESTEL 分析
  • 行業分析——波特五力
  • 管道分析

4 子宮內膜異位症治療市場：細分分析，按治療類型，2018-2030 年（百萬美元）

  • 子宮內膜異位症治療市場：治療類型變化分析
  • 止痛藥
  • 激素療法

5 子宮內膜異位症治療市場：細分分析，按藥物類別，2018-2030 年（百萬美元）

  • 子宮內膜異位症治療：藥物類別變異分析
  • 非甾體抗炎藥
  • 口服避孕藥
  • 促性腺激素釋放激素
  • 其他

6 子宮內膜異位症治療市場：細分分析，按給藥途徑，2018-2030 年（百萬美元）

  • 子宮內膜異位症治療市場：給藥途徑、變異分析
  • 口服
  • 可注射的
  • 其他

第 7 章子宮內膜異位症治療市場：細分分析，按分銷渠道，2018-2030 年（百萬美元）

  • 子宮內膜異位症治療市場：分銷渠道、變化分析
  • 醫院藥房
  • 零售藥店
  • 其他

8 子宮內膜異位症治療市場：細分分析，按地區，2018-2030 年（百萬美元）

  • 區域市場快照
  • 2021 年和 2030 年區域市場份額分析
  • 市場規模、預測以及收入和趨勢分析，2021-2030 年
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 西班牙
      • 法國
      • 意大利
      • 丹麥
      • 瑞典
      • 挪威
      • 歐洲其他地區
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 澳大利亞
      • 韓國
      • 泰國
      • 亞太地區其他國家
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 拉丁美洲其他地區
    • 多邊環境協定
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國
      • 科威特
      • MEA分辨率

第九章子宮內膜異位症治療市場：競爭分析

  • 戰略舉措和影響分析：主要市場參與者
    • 協同效應分析：重大交易和戰略聯盟
      • 新產品發布
      • 併購
      • 許可協議
  • 公司分類
    • 創新者
    • 市場領導者
    • 新興玩家
    • 熱圖分析
  • 公司市場分析
  • 供應商情況
    • 主要經銷商及渠道合作夥伴名單
    • 潛在最終用戶列表
    • 2021 年主要參與者的市場份額分析
    • 消費者行為分析
    • 競爭儀錶盤分析
  • 民營企業
    • 主要初創企業名單
    • 區域網絡圖
  • 公司簡介
    • Bayer AG
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Pfizer, Inc
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • AbbVie, Inc
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • AstraZeneca
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • ObsEva SA
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Teva Pharmaceutical Industries
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Zydus Healthcare Limited
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Eli Lilly and Company
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Astellas Pharma Inc
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68040-005-5

Endometriosis Treatment Market Growth & Trends:

The global endometriosis treatment market size is expected to reach USD 3.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is exected to expand at a CAGR of 13.5% from 2023 to 2030. The market growth is attributed to the presence of a late-stage robust product pipeline, the global upsurge in cases, and several initiatives undertaken by the government and key players at national and international levels to raise disease awareness.

The growing research and development for new treatment options in space is expected to offer a lucrative opportunity for market growth in the coming years. The launch of Myovant / Pfizer's Relugolix combination tablet, ObsEva's Yselty (linzagolix), and Ferring Pharmaceuticals / Novartis' Quinagolide are among prominent drug launches in this space that are anticipated to fuel the market growth.

Rising demand for endometriosis treatment is attributed to increasing disease burden and delay in diagnosis, worsening the disease condition. In March 2021, as per WHO, approximately 10% of female reproductive population is affected by the disease worldwide. According to the article, "Impact of Endometriosis Diagnostic Delays on Healthcare Resource Utilization and Costs", a delay of three or more years in diagnosis from developing first symptom leads to increase in symptom burden and increase in healthcare cost by 50% compared with patients who were diagnosed earlier after symptom onset.

WHO, national governments, and private organizations are strategically involved in spreading awareness and educating people about endometriosis and its treatment, thereby supporting market growth. For instance, in March 2022, the Endometriosis Foundation of America hosted four weekends of the virtual program featuring patients and physicians, helping to connect endometriosis warriors and share their experiences with the disease. Moreover, in March 2022, Endometriosis U.K. also launched an eight-point action plan during the 'Endometriosis Action Month'.

Furthermore, key players are undertaking strategic initiatives such as mergers and acquisitions, collaborations, financial investments, and geographical expansion fueling the endometriosis treatment market. For instance, in November 2021, Organon and Co. announced to acquire Forendo Pharma, which will support Forendo's development of novel drugs in endometriosis like OR-6219, a phase 2 clinical candidate.

Endometriosis Treatment Market Report Highlights:

  • By treatment type, the hormone therapy segment accounted for the largest share of the market in 2022 due to the high prescription rate of these drugs by physicians
  • Gonadotropin-releasing hormone (GnRH) segment dominated the drug class segment in 2022 due to the high efficacy of GnRH agonists and GnRH antagonists and the increased availability of these products in the market
  • In 2022, oral segment dominated the market with a 48.46% share by route of administration. It is the most common & convenient route of delivery for the majority of products in this space
  • In 2022, retail pharmacy segment dominatedthe market by distribution channel. Moreover, hospital pharmacy is expected to demonstrate moderate growth
  • North America dominated the global market in 2021 owing to increased disease incidence and high awareness among people and healthcare professionals about the condition therapies

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation and Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Snapshot

Chapter 3 Endometriosis Treatment: Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Regulatory Landscape
  • 3.4 Market Dynamics
  • 3.5 Market Driver Analysis
    • 3.5.1 Rising disease burden
    • 3.5.2 Growing awareness for the disease
    • 3.5.3 Increasing funding for research and development
  • 3.6 Market Restraint Analysis
      • 3.6.1.1 Availability of over the counter and generic drugs
  • 3.7 PESTEL Analysis
  • 3.8 Industry Analysis-Porter's Five Forces
  • 3.9 Pipeline Analysis

Chapter 4 Endometriosis Treatment Market: Segment Analysis, by Treatment Type, 2018 - 2030 (USD Million)

  • 4.1 Endometriosis Treatment Market: Treatment Type Movement Analysis
  • 4.2 Pain Medication
    • 4.2.1 Pain Medication Market, 2018 - 2030 (USD Million)
  • 4.3 Hormonal Therapy
    • 4.3.1 Hormonal Therapy Market, 2018 - 2030 (USD Million)

Chapter 5 Endometriosis Treatment Market: Segment Analysis, by Drug Class, 2018 - 2030 (USD Million)

  • 5.1 Endometriosis Treatment: Drug Class Movement Analysis
  • 5.2 NSAIDs
    • 5.2.1 NSAIDs Market, 2018 - 2030 (USD Million)
  • 5.3 Oral Contraceptive
    • 5.3.1 Oral Contraceptive Market, 2018 - 2030 (USD Million)
  • 5.4 Gonadotropin Releasing Hormone
    • 5.4.1 Gonadotropin Releasing Hormone, Market, 2018 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Endometriosis Treatment Market: Segment Analysis, by Route of Administration, 2018 - 2030 (USD Million)

  • 6.1 Endometriosis Treatment Market: Route of Administration, Movement Analysis
  • 6.2 Oral
    • 6.2.1 Oral Market, 2018 - 2030 (USD Million)
  • 6.3 Injectable
    • 6.3.1 Injectable Market, 2018 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 Endometriosis Treatment Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

  • 7.1 Endometriosis Treatment Market: Distribution Channel, Movement Analysis
  • 7.2 Hospital pharmacy
    • 7.2.1 Hospital pharmacy Market, 2018 - 2030 (USD Million)
  • 7.3 Retail pharmacy
    • 7.3.1 Retail pharmacy Market, 2018 - 2030 (USD Million)
  • 7.4 Others
    • 7.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8 Endometriosis Treatment Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 8.1 Regional Market Snapshot
  • 8.2 Regional Market Share Analysis, 2021 & 2030
  • 8.3 Market Size, Forecasts, and Revenue & Trend Analysis, 2021 to 2030
    • 8.3.1 North America
      • 8.3.1.1 North America Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.2 U.S.
      • 8.3.1.2.1 U.S. Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.3 Canada
      • 8.3.1.3.1 Canada Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 Europe
      • 8.3.2.1 Europe Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.2 U.K.
      • 8.3.2.2.1 U.K. Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.3 Germany
      • 8.3.2.3.1 Germany Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.4 Spain
      • 8.3.2.4.1 Spain Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.5 France
      • 8.3.2.5.1 France Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.6 Italy
      • 8.3.2.6.1 Italy Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.7 Denmark
      • 8.3.2.7.1 Denmark Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.8 Sweden
      • 8.3.2.8.1 Sweden Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.9 Norway
      • 8.3.2.9.1 Norway Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.2.10 Rest of Europe
      • 8.3.2.10.1 Rest of Europe Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.3 Asia Pacific
      • 8.3.3.1 Asia Pacific Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.2 Japan
      • 8.3.3.2.1 Japan Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.3 China
      • 8.3.3.3.1 China Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.4 India
      • 8.3.3.4.1 India Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.5 Australia
      • 8.3.3.5.1 Australia Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.6 South Korea
      • 8.3.3.6.1 South Korea Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.7 Thailand
      • 8.3.3.7.1 Thailand Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.3.8 Rest of APAC
      • 8.3.3.8.1 Rest of APAC Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 Latin America
      • 8.3.4.1 Latin America Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.4.2 Brazil
      • 8.3.4.2.1 Brazil Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.4.3 Mexico
      • 8.3.4.3.1 Mexico Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.4.4 Argentina
      • 8.3.4.4.1 Argentina Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.4.4 Rest of LATAM
      • 8.3.4.5.1 Rest of LATAM Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 MEA
      • 8.3.5.1 MEA Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.5.2 South Africa
      • 8.3.5.2.1 South Africa Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.5.3 Saudi Arabia
      • 8.3.5.3.1 Saudi Arabia Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.5.4 UAE
      • 8.3.5.4.1 UAE Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.5.4 Kuwait
      • 8.3.5.4.1 KuwaitEndometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 8.3.5.4 Reso of MEA
      • 8.3.5.4.1 Rest of MEA Endometriosis Treatment Market Estimates and Forecast, 2018 - 2030 (USD Million)

Chapter 9 Endometriosis Treatment Market: Competitive Analysis

  • 9.1 Strategic Initiatives and Impact Analysis, by Key Market Participants
    • 9.1.1 Synergy Analysis: Major Deals and Strategic Alliances
      • 9.1.1.1 New Product Launches
      • 9.1.1.2 Mergers and Acquisitions
      • 9.1.1.3 Licensing Agreements
  • 9.2 Company Categorization
    • 9.2.1 Innovators
    • 9.2.2 Market Leaders
    • 9.2.3 Emerging Players
    • 9.2.4 Heat Map Analysis
  • 9.3 Company Market Position Analysis
  • 9.4 Vendor Landscape
    • 9.4.1 List of Key Distributors and Channel Partners
    • 9.4.2 List of Potential End-Users
    • 9.4.3 Key Company Market Share Analysis, 2021
    • 9.4.4 Consumer Behavior Analysis
    • 9.4.5 Competitive Dashboard Analysis
  • 9.5 Private Companies
    • 9.5.1 List of Key Emerging Companies
    • 9.5.2 Regional Network Map
  • 9.6 Company Profiles
    • 9.6.1 Bayer AG
      • 9.6.1.1 Company Overview
      • 9.6.1.2 Financial Performance
      • 9.6.1.3 Product Benchmarking
      • 9.6.1.4 Strategic Initiatives
    • 9.6.2 Pfizer, Inc
      • 9.6.2.1 Company Overview
      • 9.6.2.2 Financial Performance
      • 9.6.2.3 Product Benchmarking
      • 9.6.2.4 Strategic Initiatives
    • 9.6.3 AbbVie, Inc
      • 9.6.3.1 Company Overview
      • 9.6.3.2 Financial Performance
      • 9.6.3.3 Product Benchmarking
      • 9.6.3.4 Strategic Initiatives
    • 9.6.4 AstraZeneca
      • 9.6.4.1 Company Overview
      • 9.6.4.2 Financial Performance
      • 9.6.4.3 Product Benchmarking
      • 9.6.4.4 Strategic Initiatives
    • 9.6.5 ObsEva SA
      • 9.6.5.1 Company Overview
      • 9.6.5.2 Financial Performance
      • 9.6.5.3 Product Benchmarking
      • 9.6.5.4 Strategic Initiatives
    • 9.6.6 Teva Pharmaceutical Industries
      • 9.6.6.1 Company Overview
      • 9.6.6.2 Financial Performance
      • 9.6.6.3 Product Benchmarking
      • 9.6.6.4 Strategic Initiatives
    • 9.6.7 Zydus Healthcare Limited
      • 9.6.7.1 Company Overview
      • 9.6.7.2 Financial performance
      • 9.6.7.3 Product Benchmarking
      • 9.6.7.4 Strategic Initiatives
    • 9.6.8 Eli Lilly and Company
      • 9.6.8.1 Company Overview
      • 9.6.8.2 Financial performance
      • 9.6.8.3 Product Benchmarking
      • 9.6.8.4 Strategic Initiatives
    • 9.6.9 Astellas Pharma Inc
      • 9.6.9.1 Company Overview
      • 9.6.9.2 Financial performance
      • 9.6.9.3 Product Benchmarking
      • 9.6.9.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 List of Parameters
  • Table 4 List of Distributors
  • Table 5 Global Endometriosis Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 Global Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 7 Global Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 8 Global Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9 Global Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 10 North America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 North America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 12 North America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 13 North America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 14 North America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 U.S. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 17 U.S. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 U.S. Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Canada Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 20 Canada Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Canada Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 Canada Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 Europe Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 24 Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 25 Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 26 Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 27 Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28 Germany Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 29 Germany Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 30 Germany Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 Germany Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 U.K. Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 33 U.K. Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 34 U.K. Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 35 U.K. Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 36 France Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 37 France Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 38 France Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 39 France Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40 Italy Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 41 Italy Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 42 Italy Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 43 Italy Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Spain Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 45 Spain Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 46 Spain Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 47 Spain Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Denmark Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 49 Denmark Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 50 Denmark Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 51 Denmark Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 52 Sweden Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 53 Sweden Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 54 Sweden Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 55 Sweden Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 Norway Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 57 Norway Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 58 Norway Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 59 Norway Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 Rest of Europe Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 61 Rest of Europe Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 62 Rest of Europe Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 63 Rest of Europe Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Japan Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 70 Japan Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 71 Japan Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 72 Japan Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 China Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 74 China Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 75 China Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 76 China Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 77 India Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 78 India Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 79 India Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 80 India Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 81 South Korea Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 82 South Korea Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 83 South Korea Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 84 South Korea Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 Australia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 86 Australia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 87 Australia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 88 Australia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 Thailand Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 90 Thailand Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 91 Thailand Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 92 Thailand Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 93 Rest of Asia Pacific Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 94 Rest of Asia Pacific Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 95 Rest of Asia Pacific Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 96 Rest of Asia Pacific Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 97 Latin America Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 98 Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 99 Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 100 Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 101 Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 102 Brazil Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 103 Brazil Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 104 Brazil Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 105 Brazil Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 106 Mexico Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 107 Mexico Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 108 Mexico Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 109 Mexico Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 110 Argentina Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 111 Argentina Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 112 Argentina Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 113 Argentina Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 114 Rest of Latin America Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 115 Rest of Latin America Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 116 Rest of Latin America Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 117 Rest of Latin America Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 118 Middle East & Africa Endometriosis Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 119 Middle East & Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 120 Middle East & Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 121 Middle East & Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 122 Middle East & Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 123 Saudi Arabia Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 124 Saudi Arabia Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 125 Saudi Arabia Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 126 Saudi Arabia Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 127 South Africa Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 128 South Africa Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 129 South Africa Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 130 South Africa Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 131 UAE Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 132 UAE Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 133 UAE Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 134 UAE Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 135 Kuwait Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 136 Kuwait Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 137 Kuwait Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 138 Kuwait Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 139 Rest of MEA Endometriosis Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 140 Rest of MEA Endometriosis Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 141 Rest of MEA Endometriosis Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 142 Rest of MEA Endometriosis Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Endometriosis Treatment Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Commodity Flow Approach
  • Fig. 10 Market Snapshot (2022) (USD Million)
  • Fig. 11 Segment Snapshot (2022) (USD Million)
  • Fig. 12 Competitive Snapshot
  • Fig. 13 Penetration & Growth Prospect Mapping
  • Fig. 14 Endometriosis Treatment Market Driver Impact
  • Fig. 15 Endometriosis Treatment Market Restraint Impact
  • Fig. 16 PESTEL Analysis
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 Endometriosis Treatment, Treatment Type Outlook: Key Takeaways
  • Fig. 19 Endometriosis Treatment Market: Treatment Type Movement Analysis (USD Million)
  • Fig. 20 Pain Medication Market 2018 - 2030 (USD Million)
  • Fig. 21 Hormone Therapy Market, 2018 - 2030 (USD Million)
  • Fig. 22 Endometriosis Treatment Market: Drug Class Movement Analysis (USD Million)
  • Fig. 23 NSAIDs Market, 2018 - 2030 (USD Million)
  • Fig. 24 Oral Contraceptive, Market, 2018 - 2030 (USD Million)
  • Fig. 25 Progestin Market, 2018 - 2030 (USD Million)
  • Fig. 26 Gonadotropin Releasing Hormone Market, 2018 - 2030 (USD Million)
  • Fig. 27 Danazol Market, 2018 - 2030 (USD Million)
  • Fig. 28 Others Market, 2018 - 2030 (USD Million)
  • Fig. 29 Endometriosis Treatment, Route of Administartion Outlook: Key Takeaways
  • Fig. 30 Endometriosis Treatment Market: Route of Administartion Movement Analysis (USD Million)
  • Fig. 31 Oral Market, 2018 - 2030 (USD Million)
  • Fig. 32 Injectable Market, 2018 - 2030 (USD Million)
  • Fig. 33 Others Market, 2018 - 2030 (USD Million)
  • Fig. 34 Endometriosis Treatment Market Distribution Channel Outlook: Key Takeaways
  • Fig. 35 Hospital pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 36 Retail pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 37 Others Market, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Snapshot, 2021 & 2030
  • Fig. 39 Regional Market Place: Key takeaways
  • Fig. 40 North America
  • Fig. 41 North America Endometriosis Treatment Market, 2018 - 2030 (USD million)
  • Fig. 42 U.S.
  • Fig. 43 U.S. Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada
  • Fig. 45 Canada Endometriosis Treatment Market, 2018 - 2030 (USD million)
  • Fig. 46 Europe
  • Fig. 47 Europe Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 48 U.K.
  • Fig. 49 U.K. Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany
  • Fig. 51 Germany Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 52 Spain
  • Fig. 53 Spain Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 54 France
  • Fig. 55 France Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Italy
  • Fig. 57 Italy Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark
  • Fig. 57 Denmark Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden
  • Fig. 57 Sweden Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Norway
  • Fig. 57 Norway Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 56 Rest of Europe
  • Fig. 57 Rest of Europe Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific
  • Fig. 59 Asia Pacific Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 60 Japan
  • Fig. 61 Japan Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 62 China
  • Fig. 63 China Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 64 India
  • Fig. 65 India Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 66 Australia
  • Fig. 67 Australia Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea
  • Fig. 69 South Korea Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 70 Thailand
  • Fig. 71 Thailand Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 72 Rest of APAC
  • Fig. 73 Rest of APAC Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America
  • Fig. 75 Latin America Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 76 Brazil
  • Fig. 77 Brazil Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 78 Mexico
  • Fig. 79 Mexico Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina
  • Fig. 81 Argentina Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 82 Rest of LATAM
  • Fig. 83 Rest of LATAM Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 84 Middle East & Africa
  • Fig. 85 MEA Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa
  • Fig. 87 South Africa Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia
  • Fig. 89 Saudi Arabia Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 90 UAE
  • Fig. 91 UAE Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 92 Kuwait
  • Fig. 93 Kuwait Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 94 Rest of MEA
  • Fig. 95 Rest of MEA Endometriosis Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 96 Heat Map Analysis
  • Fig. 97 Company Market Position Analysis, 2021
  • Fig. 98 Company Market Position Analysis, 2021
  • Fig. 99 Company Market Share Analysis (2021)
  • Fig. 100 Consumer Behavior Analysis
  • Fig. 101 Market Differentiators